You are more likely to contract Covid at home

To keep you updated, we send Daily Newsletter to your mailbox. In case, you wish to Unsubscribe Click Here

Daily Newsletter Wed, Jul 22, 2020 | 03:54 PM IST

#ImpactOfTrumpVisaBan#AllAboutH-1BVisa#Coronavirus#EconomyTracker#Whatsbuzzing

Top stories of the day Not stepping out? People are more likely to contract coronavirus at home Most corona-positive people end up infecting their own families. ... Mercedes engineers tell you why Tesla is the car company to beat Gold crosses Rs 50,000-mark for first time At least 2 years to vaccinate 70% of India India's battered property market finds a hero Top start-up boss rewards team with ESOPs Cases spike among India's factory workers New study cautions against herd immunity

Long Reads Why doctors are writing favipiravir for Covid despite limited data Last month, India's drug regulator granted emergency-use authorisation for favipiravir to treat Covid-19, making it the first oral anti-viral drug approved for such use. However, Glenmark, which launched the favipiravir brand FabiFlu, hasn't yet disclosed data of its clinical trial on 150 patients o the assess the drug's safety and efficacy.

SENSEX 37871.52 -58.81 NIFTY 50 11132.60 -29.65 USD/INR 74.76 0.01

Top Gainers NSE 5 companies (largecap) appreciated more than 5% M&M Financial 10.72% Hindustan Zinc 7.90% More from Gainers Top Losers NSE 11 companies (largecap) price decreased more than -3% Aarti Surfactants Ltd. -4.99% Ksolves India Ltd. -4.47% More from Losers

More From our Partners BMW logo has changed for the first time in decades

Founder who pledged his organs for money is now South Korea's second-richest person His rise is extraordinary and represents a shift in the country's business elite. While family-run conglomerates touc... Tax on gifts: Documents that you should have Corp FDs attractive for seniors despite rate cuts Fresh US stimulus would matter, not EU package Tensions escalate between US and China NPCI launches UPI AutoPay feature for payments Gehlot's brother raided in fertilizer scam IT, BPO staff can work from home till December

More From our Partners Commemorating contribution of COVID warriors with Find X2 Series

Top Slideshow Do tough work visa rules lead to more domestic job creation? Top Video ET Catalyse: Is it time to reimagine education?

Follow Us on ET:

About us|Advertise with us|Feedback|Sitemap|Code of Ethics © 2020 Times Internet Limited.

To ensure delivery directly to your inbox, please add etnotifications@indiatimes.com to your address book today. If you are having trouble viewing this newsletter, please click here

To unsubscribe or edit your subscriptions please click here

China's Lehman moment

To keep you updated, we send Daily Newsletter to your mailbox. In case, you wish to Unsubscribe Click Here

Daily Newsletter Tue, Jul 21, 2020 | 04:21 PM IST

#ImpactOfTrumpVisaBan#AllAboutH-1BVisa#Coronavirus#EconomyTracker#Whatsbuzzing

Top stories of the day Saddled with risky financial assets, China is getting dangerously close to its Lehman moment China's Lehman moment, when isolated events cross the line into systemic effects, is just lurking around the corner.... Rahul Bajaj to step down as Bajaj Finance chairman Why you lose so much when breaking bank FD For Modi, helicopter money is an idea best left alone US will let Americans sue China for the virus Serum Institute to apply for local trials Britannia plans to keep 'Good Days' going What is making top CEOs 'more cautious'

Debate This Is it too early to talk of an economic recovery? The economy was cratering even before the pandemic hit, with demand stagnation leading to declining GDP growth over successive quarters. The lockdown just made it worse. Now as India slowly reopens, the needle seems to be moving, but is it enough? While the supply-side problems that affected the economy in the beginning of the lockdown have been largely sorted, things are far from normal.

SENSEX 37930.33 511.34 NIFTY 50 11162.25 140.05 USD/INR 74.74 -0.18

Top Gainers NSE 6 companies (largecap) appreciated more than 5% Piramal Ent. 10.81% Bank of India 6.69% More from Gainers Top Losers NSE 6 companies (largecap) price decreased more than -3% Aarti Surfactants Ltd. -5.00% Bajaj Finance -4.33% More from Losers

More From our Partners BMW logo has changed for the first time in decades

Delays to key India shadow bank insolvency show coronavirus pandemic fallout Payments to creditors from Infrastructure Leasing & Financial Services Ltd., whose default in September 2018 triggere... Many vaccine tests raise new challenge Coronavirus not as lethal as it was feared And the post-coronavirus world belongs too... A contract puts India's oldest alliances to test

More From our Partners Commemorating contribution of COVID warriors with Find X2 Series

Top Slideshow Indian Navy's eyes in the Indian Ocean Region Top Video Sensex climbs 511 pts; Nifty50 tops 11,150

Follow Us on ET:

About us|Advertise with us|Feedback|Sitemap|Code of Ethics © 2020 Times Internet Limited.

To ensure delivery directly to your inbox, please add etnotifications@indiatimes.com to your address book today. If you are having trouble viewing this newsletter, please click here

To unsubscribe or edit your subscriptions please click here